H Stuart Campbell Sells 989 Shares of Mesa Laboratories, Inc. (MLAB) Stock

Mesa Laboratories, Inc. (NASDAQ:MLAB) Director H Stuart Campbell sold 989 shares of the firm’s stock in a transaction that occurred on Monday, June 11th. The shares were sold at an average price of $191.17, for a total value of $189,067.13. Following the completion of the transaction, the director now owns 41,527 shares in the company, valued at approximately $7,938,716.59. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Mesa Laboratories opened at $202.02 on Friday, Marketbeat reports. Mesa Laboratories, Inc. has a twelve month low of $122.35 and a twelve month high of $211.55. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.32 and a current ratio of 1.85. The company has a market capitalization of $787.70 million, a PE ratio of 62.87 and a beta of 0.47.

Mesa Laboratories (NASDAQ:MLAB) last posted its earnings results on Tuesday, June 5th. The medical instruments supplier reported $1.08 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.84 by $0.24. Mesa Laboratories had a positive return on equity of 12.93% and a negative net margin of 3.08%. The company had revenue of $26.88 million for the quarter, compared to analyst estimates of $25.40 million. equities research analysts anticipate that Mesa Laboratories, Inc. will post 6.84 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Friday, June 15th. Investors of record on Thursday, May 31st were given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.32%. The ex-dividend date was Wednesday, May 30th. Mesa Laboratories’s payout ratio is 10.36%.

A number of research analysts have recently weighed in on the company. ValuEngine lowered Mesa Laboratories from a “buy” rating to a “hold” rating in a report on Tuesday, May 22nd. BidaskClub upgraded Mesa Laboratories from a “hold” rating to a “buy” rating in a report on Friday, June 8th. Finally, Zacks Investment Research upgraded Mesa Laboratories from a “sell” rating to a “hold” rating in a report on Wednesday, February 28th.

Several institutional investors and hedge funds have recently modified their holdings of MLAB. Schwab Charles Investment Management Inc. increased its position in shares of Mesa Laboratories by 18.8% during the fourth quarter. Schwab Charles Investment Management Inc. now owns 14,223 shares of the medical instruments supplier’s stock valued at $1,768,000 after acquiring an additional 2,247 shares during the last quarter. Comerica Bank increased its position in shares of Mesa Laboratories by 86.2% during the fourth quarter. Comerica Bank now owns 6,481 shares of the medical instruments supplier’s stock valued at $849,000 after acquiring an additional 3,000 shares during the last quarter. Candriam Luxembourg S.C.A. increased its position in shares of Mesa Laboratories by 20.0% during the fourth quarter. Candriam Luxembourg S.C.A. now owns 7,200 shares of the medical instruments supplier’s stock valued at $895,000 after acquiring an additional 1,200 shares during the last quarter. Keybank National Association OH increased its position in shares of Mesa Laboratories by 13.2% during the fourth quarter. Keybank National Association OH now owns 3,850 shares of the medical instruments supplier’s stock valued at $479,000 after acquiring an additional 450 shares during the last quarter. Finally, Wells Fargo & Company MN increased its position in shares of Mesa Laboratories by 35.0% during the fourth quarter. Wells Fargo & Company MN now owns 5,902 shares of the medical instruments supplier’s stock valued at $734,000 after acquiring an additional 1,531 shares during the last quarter. 73.68% of the stock is owned by institutional investors.

About Mesa Laboratories

Mesa Laboratories, Inc designs, manufactures, and markets quality control instruments and disposable products. The company's Instruments segment offers data loggers, which are precision instruments used in critical manufacturing, quality control, and validation applications; medical meters and calibration solutions used to test various parameters of the dialysis fluid, and the calibration and operation of the dialysis machine; gas flow calibration and air sampling equipment that are used for industrial hygiene assessments, calibration of gas metering equipment, and environmental air monitoring; and torque testing systems used for measure bottle cap tightness.

Insider Buying and Selling by Quarter for Mesa Laboratories (NASDAQ:MLAB)

Receive News & Ratings for Mesa Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply